|
| Identification of chemical compounds of Shi-Jue-Ming-San based on ultra-high performance liquid chromatography-quadrupole Orbitrap mass spectrometry and its network pharmacology in treatment of hypertension |
| Hits 64 Download times 33 Received:April 18, 2024 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2024.09.04 |
| Key Words
Shi-Jue-Ming-San;chemical composition;hypertension;network pharmacology;mechanism of action |
| Author Name | Affiliation | E-mail | | MI Wei | Tianjin Chest Hospital, Tianjin 300350, China | | | WANG Ying | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | | | FU Zhifei | Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China | fuzhifei@tjutcm.edu.cn |
|
| Abstract
|
| [Objective] Based on the analysis of absorbed components in blood and network pharmacology,the potential mechanism of Shi-Jue-Ming-San(SJMS) in treating hypertension(HT) was explored. [Methods] Qualitative analysis was conducted on the main chemical compounds in vivo and in vitro of SJMS using the ultra-high performance liquid chromatography-quadrupole Orbitrap mass spectrometry(UHPLC/Q-Orbitrap-MS),and the targeted protein of active compounds were predicted using SEA and SwissTargetPrediction databases; Using GeneCards and DrugBank databases to obtain relevant targets for hypertension; Construct a PPI network for potential targets of SJMS on HT using the String platform and Cytoscape software; Perform GO functional enrichment analysis and KEGG metabolic pathway enrichment analysis on intersection targets using the DAVID database; Finally, a "component-disease-pathway-target" network diagram was constructed using Cytoscape software for analysis. [Results] 129 main chemical compounds and 23 prototype components in blood were identified in SJMS; A total of 296 intersection targets were obtained,among which SRC,TP53,STAT3,EGFR,AKT1,ESR1 are key targets for SJMS anti-HT. The main active ingredients of SJMS for anti-HT include aurantio-obtusin,rubrofusarin-6-O-β-gentiobioside,torachrysone,glycyrrhetinic acid,neochlorogenic acid,glycyrrhizictinic acid,apigenin; GO enriched 30 gene function entries(P<0.01),and the activity of SJMS was negatively related to protein phosphorylation,and apoptosis process,while positively related to cell proliferation. There were 20 of KEGG pathways(P<0.01). The results showed that SJMS played a role in treating HT mainly through HIF-1 signaling pathway and AGE-RAGE signaling pathway in diabetes complications. [Conclusion] This study preliminarily elucidates the potential pharmacological substance basis of SJMS and explores its potential mechanism of action against HT,providing a certain theoretical reference for its clinical application. |
|
|
|
|
|
